RaQualia Pharma

4579.TTSE GROWTHPharmaceutical

Key numbers · FY ended 2025-12

Operating income¥484m—Net income (owners)¥273m—Total assets¥10.5bn+8.9% YoY EPS (basic)¥11.53+150.4% YoY

Full financial history and reports →

Stock price4579 · View chart ↗

Open the price chart on TradingView.

Latest filings

Thu, Jan 29 · JST2 filings

16:025% STAKERaQualia Pharma · YUICHI KAKINUMA + 1 joint holder · 20.35% → 25.11%+4.76pp 15:595% STAKERaQualia Pharma · HK inno.N Corporation + 1 joint holder · 20.35% → 25.11%+4.76pp

Fri, Apr 18 · JST3 filings

15:315% STAKERaQualia Pharma · KAKINUMA YUICHI + 1 joint holder · 20.37%new 20.37%15:30MATERIALRaQualia Pharma · Change in major shareholder 14:485% STAKERaQualia Pharma · HK inno.N Corporation + 1 joint holder · 20.37%new 20.37%

All filings →

Major holders (5%+) · 3

Holder	Stake	Change	Filed
HK inno.N Corporationjoint holder	15.94%	0.00pp	2026-01-29
YUICHI KAKINUMA	9.17%	0.00pp	2026-01-29
Heights Capital Management, Inc.	5.41%	—	2025-03-31

Each holder's own ratio from its most recent large-shareholding report.